New herpes drug ABI-1179 passes first safety check in small study
NCT ID NCT06698575
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 22 times
Summary
This early-stage study tested a new drug called ABI-1179 in 103 people. First, healthy volunteers received a single dose to check safety. Then, people with recurrent genital herpes (caused by HSV-2) received multiple doses. The main goal was to see if the drug is safe and how the body processes it. This is a first step toward finding a new treatment option for genital herpes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT GENITAL HERPES SIMPLEX TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alliance for Multispecialty Research
Kansas City, Missouri, 64114, United States
-
Canopy Clinical Wollongong
Wollongong, Australia, 2500, Australia
-
East Sydney Doctors
Darlinghurst, Australia, 2010, Australia
-
Momentum Clinical Research
Sydney, Australia, 2010, Australia
-
Momentum Kapiti
Waikanae, New Zealand, 5036, New Zealand
-
Momentum Palmerston North
Palmerston North, New Zealand, 4414, New Zealand
-
Momentum Sunshine
Melbourne, Au, 3021, Australia
-
New Zealand Clinical Research
Auckland, New Zealand, 1010, New Zealand
-
New Zealand Clinical Research
Christchurch, New Zealand, 8011, New Zealand
-
Pacific Clinical Research Network
Nelson, New Zealand, 7011, New Zealand
-
Pacific Clinical Research Network
Rotorua, New Zealand, 3010, New Zealand
-
Pacific Clinical Research Network
Upper Hutt, New Zealand, 5018, New Zealand
-
Pacific Clinical Research Network
Hamilton, New, 3200, New Zealand
-
Rochester Clinical Research
Rochester, New York, 14609, United States
-
Royal Melbourne Hospital
Parkville, Australia, 3050, Australia
-
Seattle Clinical Research Center
Seattle, Washington, 98104, United States
-
Taylor Square Private Clinic
Surry Hills, Australia, 2010, Australia
-
University of Washington Virology Research Clinic
Seattle, Washington, 98104, United States
Conditions
Explore the condition pages connected to this study.